Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant in Fibromyalgia with Comorbid Insomnia
NCT02684136Phase 4Terminated
- Sponsor
- Henry Ford Health
- Start
- Feb 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suvorexant in fibromyalgia (FM), Insomnia, sponsored by Henry Ford Health. Started Feb 2016; status: terminated.
02
Drugs
suvorexant
03
Conditions
fibromyalgia (FM)Insomnia
Beyond the preview
Go deeper on NCT02684136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684136.